ANIP FY 2015 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$76M+36.4% YoY

Gross Profit

$64M83.4% margin

Operating Income

$33M42.8% margin

Net Income

$15M20.1% margin

EPS (Diluted)

$1.32

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

-$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$285M

Total Liabilities

$125M

Stockholders' Equity

$160M

Cash & Equivalents

$155M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$56M	+36.4%
Gross Profit	$64M	$44M	+43.0%
Operating Income	$33M	$20M	+63.5%
Net Income	$15M	$29M	-46.5%